Patient-centered Pharmacist Care in the Hemodialysis Unit: a quasi-experimental interrupted time series study

BMC Nephrology

Table 2 Results of regression models for the study outcomes

Outcome	Fitted Mean at baseline	Coefficient before intervention ^a	Coefficient after intervention ^b	p-value	χ²
Primary outcomes
I) Subjective: Self-reported vs. electronic records	1.237 ^c	−0.305	−0.072	0.348	2.11
II) Surrogate:Pre-dialysis phosphate level (mmol/L) ^d	1.536	− 0.088	−0.01	0.682	0.77
Secondary outcomes
Systolic blood pressure (mmHg)	137.154	−0.623	−2.576	0.083	4.98
Low-density lipoprotein (mmol/L) ^e	1.666	−0.754	−0.094	0.096	4.69

^a The coefficient of the slope of the fitted line presenting months before the intervention, ^b The coefficient of the slope of the fitted line presenting months after the intervention, ^c Mean differences in the number of oral medications between self-reporting and electronic records at baseline, ^d The normal range for phosphate levels is 0.8–1.44 mmol/L, which is the target level for hemodialysis patients, ^e Low density lipoprotein levels for patients who received lipid-lowering agents (statins)

ISSN: 1471-2369